Connection

Chrystal Paulos to Recombinant Fusion Proteins

This is a "connection" page, showing publications Chrystal Paulos has written about Recombinant Fusion Proteins.
Connection Strength

0.590
  1. Novel immunotherapies for hematologic malignancies. Immunol Rev. 2015 Jan; 263(1):90-105.
    View in: PubMed
    Score: 0.421
  2. Targeted Complement Inhibition Protects Vascularized Composite Allografts From Acute Graft Injury and Prolongs Graft Survival When Combined With Subtherapeutic Cyclosporine A Therapy. Transplantation. 2017 04; 101(4):e75-e85.
    View in: PubMed
    Score: 0.123
  3. Identification of chimeric antigen receptors that mediate constitutive or inducible proliferation of T cells. Cancer Immunol Res. 2015 Apr; 3(4):356-67.
    View in: PubMed
    Score: 0.026
  4. Multiple injections of electroporated autologous T cells expressing a chimeric antigen receptor mediate regression of human disseminated tumor. Cancer Res. 2010 Nov 15; 70(22):9053-61.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.